DE:3XV Stock Latest News
Company AnnouncementsXVIVO Perfusion AB Signals Strong Growth in Earnings Call1w ago
Company AnnouncementsXvivo Perfusion Boosts Sales and Profit as Heart R&D Spend Rises1w ago
Pre-EarningsXVIPF Upcoming Earnings Report: What to Expect?1w ago
Company AnnouncementsXVIVO Perfusion Sets October 22 Call for Q3 2026 Interim Report2w ago
Company AnnouncementsXVIVO Perfusion Sets 2027 Nomination Committee and Invites Shareholder Input1M ago
Company AnnouncementsXVIVO Files FDA PMA for Heart Assist Transport System After Key U.S. Trial1M agoCompany AnnouncementsXVIVO Wins CE Mark for Heart Preservation System, Expanding European Transplant Access2M ago
Company AnnouncementsXVIVO Perfusion AB Earnings Call Highlights Strong Growth3M ago- Company AnnouncementsXvivo Perfusion Delivers Strong Growth While Ramping Heart R&D Spend3M ago
- Pre-EarningsXVIPF Earnings this Week: How Will it Perform?3M ago
- Company AnnouncementsXVIVO Schedules July 14 Call to Present Q2 2026 Interim Results4M ago
Company AnnouncementsXvivo Perfusion’s Record Quarter Signals Growing Momentum5M agoCompany AnnouncementsFrench Approval and Reimbursement Open Nationwide Access to XVIVO Heart Technology5M ago
Company AnnouncementsXvivo Perfusion Earnings Call Highlights Growth And Margins6M ago
Company AnnouncementsXVIVO Perfusion AGM Backs Incentive Plan, Withholds Dividend and Expands Financing Flexibility6M ago
Company AnnouncementsXvivo Perfusion Delivers Strong Q1 Growth and Advances Heart Preservation Trials6M ago
Company AnnouncementsXVIVO Reports Strong Early Trial Results for HOPE Technology in DCD Heart Transplants6M ago
Company AnnouncementsXVIVO’s U.S. PRESERVE Trial Shows Strong One-Year Outcomes for Heart Preservation Technology6M ago